344 participants
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2026-01-07
- Completion:
- 2028-12-30
Conditions
- Pulmonary Hypertension
- Interstitial Lung Disease
Interventions
- DRUG
No Results Yet